Sunday, February 5, 2023
manilastandard.net
ADVERTISEMENT
  • About
  • News
    • Top Stories
    • National
    • World News
    • Pinoy Abroad
    • Features
  • Opinion
    • Editorial
    • Columns
    • Soundbytes
  • LGUs
    • NCR
    • Luzon
    • Visayas
    • Mindanao
  • Business
    • Corporate
    • Economy & Trade
    • Stocks
    • Money
    • Agri & Mining
    • Power & Tech
    • IT & Telecom
  • Sports
    • Basketball
    • Volleyball
    • Fightsports
    • Active
    • Sports Plus
    • One Championship
    • Columns
  • Entertainment
    • TV & Movies
    • Celebrity Profiles
    • Music & Concerts
    • Digital Media
    • Columns
  • Lifestyle
    • Food
    • Culture & Media
    • Fashion
    • Health and Home
    • Leisure
    • Shopping
    • Columns
  • Others
    • Pets
    • Pop.Life
      • Newsmakers
      • Hangouts
      • A-Pop
      • Post Its
      • Performances
      • Malls & Bazaars
      • Hobbies & Collections
    • Technology
      • Gadgets
      • Computers
      • Business
      • Tech Plus
    • MS ON THE ROAD
      • Sedan
      • SUV
      • Truck
      • Bike
      • Accessories
      • Motoring Plus
      • Commuter’s Corner
    • Home & Design
      • Residential
      • Commercial
      • Construction
      • Interior
    • Spotlight
    • Gallery
      • Photos
      • Videos
    • Events
      • Seminars
      • Exhibits
      • Community
    • Biyahero
      • Travel Features
      • Travel Reels
      • Travel Logs
  • Advertise with Us
No Result
View All Result
  • About
  • News
    • Top Stories
    • National
    • World News
    • Pinoy Abroad
    • Features
  • Opinion
    • Editorial
    • Columns
    • Soundbytes
  • LGUs
    • NCR
    • Luzon
    • Visayas
    • Mindanao
  • Business
    • Corporate
    • Economy & Trade
    • Stocks
    • Money
    • Agri & Mining
    • Power & Tech
    • IT & Telecom
  • Sports
    • Basketball
    • Volleyball
    • Fightsports
    • Active
    • Sports Plus
    • One Championship
    • Columns
  • Entertainment
    • TV & Movies
    • Celebrity Profiles
    • Music & Concerts
    • Digital Media
    • Columns
  • Lifestyle
    • Food
    • Culture & Media
    • Fashion
    • Health and Home
    • Leisure
    • Shopping
    • Columns
  • Others
    • Pets
    • Pop.Life
      • Newsmakers
      • Hangouts
      • A-Pop
      • Post Its
      • Performances
      • Malls & Bazaars
      • Hobbies & Collections
    • Technology
      • Gadgets
      • Computers
      • Business
      • Tech Plus
    • MS ON THE ROAD
      • Sedan
      • SUV
      • Truck
      • Bike
      • Accessories
      • Motoring Plus
      • Commuter’s Corner
    • Home & Design
      • Residential
      • Commercial
      • Construction
      • Interior
    • Spotlight
    • Gallery
      • Photos
      • Videos
    • Events
      • Seminars
      • Exhibits
      • Community
    • Biyahero
      • Travel Features
      • Travel Reels
      • Travel Logs
  • Advertise with Us
No Result
View All Result
manilastandard.net
No Result
View All Result
Home News World News

Pfizer strikes global licensing deal for cheap COVID-19 pill

AFPbyAFP
November 17, 2021, 7:10 pm
in World News
Reading Time: 3 mins read
A A
Share on FacebookShare on TwitterShare on Email

US pharmaceutical giant Pfizer on Tuesday announced a deal to make its prospective antiviral COVID-19 pill available more cheaply in the world’s least-wealthy countries.

Pfizer will sub-license production of its promising Paxlovid pill to generic drug manufacturers for supply in 95 low- and middle-income nations covering around 53 percent of the world’s population.

Under the deal struck with the global Medicines Patent Pool (MPP), Pfizer – which also produces one of the most widely-used COVID vaccines with German lab BioNTech – will not receive royalties from the generic manufacturers, making the treatment cheaper.

The agreement is subject to the oral antiviral medication passing ongoing trials and regulatory approval.

The Pfizer drug is to be taken with the HIV medicine ritonavir.

ADVERTISEMENT

Interim data from ongoing trials demonstrated an 89 percent reduction in the risk of COVID-19-related hospitalisation or death compared to a placebo, in non-hospitalised high-risk adults with Covid-19 within three days of symptom onset, said Pfizer.

Similar results were seen within five days of symptom onset, it added.

The Geneva-based MPP is a United Nations-backed international organisation that works to facilitate the development of medicines for low- and middle-income nations.

If approved, the pill could be on the market in “a matter of months,” MPP policy chief Esteban Burrone told AFP.

Pfizer also said Tuesday that it was seeking an emergency use authorisation, or EUA, in the US for the COVID pill.

Pfizer will forego royalties on sales in all countries covered by the agreement while COVID-19 remains classified as a Public Health Emergency of International Concern by the World Health Organization. AFP

Last month, the WHO maintained the highest level of alert over the spread of the SARS-CoV-2 virus that causes COVID-19.

Paxlovid, or PF-07321332, is an investigational antiviral therapy designed to block the activity of the SARS-CoV-2-3CL protease – an enzyme that the coronavirus needs to replicate.

Taking it together with a low dose of ritonavir helps slow the breakdown of PF-07321332. It, therefore, remains active in the body for a longer period at a high concentration, to help combat the virus.

The pill could potentially help patients avoid severe illness, which can lead to hospitalisation and death, Pfizer said.

“We believe oral antiviral treatments can play a vital role in reducing the severity of COVID-19 infections, decreasing the strain on our healthcare systems and saving lives,” said Pfizer chairman and chief executive Albert Bourla.

While a multitude of vaccines have been rolled out in the pandemic, the hunt for treatments for those who have already caught the disease has not been as fruitful.

The MPP was founded by Unitaid, which works on innovations to prevent, diagnose and treat major diseases in poorer countries.

“During a pandemic, saving time means saving lives. This agreement could help us to reach more people more quickly as soon as the medicine is approved,” said Unitaid executive director Philippe Duneton.

Potential sublicensees have until December 6 to register an expression of interest.

The announcement comes after the MPP signed a similar voluntary licensing deal with Pfizer’s US rivals Merck & Co last month for its investigational oral antiviral medicine molnupiravir.

Subject to regulatory approval, the deal will help create broad access to molnupiravir in 105 low- and middle-income countries.

Pills are easier to make than vaccines, do not require a cold chain for delivery and can be self-administered by the patient.

In terms of relieving health systems by preventing hospitalisations, “it’s a game changer,” said Burrone.

He said pricing for the Pfizer pill had not yet been set but said that “in a competitive environment… the prices tend to come down” to a low level.

Doctors Without Borders (MSF) meanwhile suggested it might cost around $700 per Pfizer treatment course, in line with molnupiravir.

The medical charity said it was disheartened by the deal, saying restrictive voluntary licences were no substitute for guaranteed global access to COVID tools to bring the pandemic under control. 

Tags: antiviral pillBioNTechCOVID-19Medicines Patent PoolPfizer
ADVERTISEMENT
AFP

AFP

Related Posts

‘Western arms won’t be used to hit Russia’

byAFP
February 5, 2023, 6:30 pm
0
8
Southwoods nails Seniors’ Fil golf crown

Ukraine’s President Volodymyr Zelensky agrees that weapons supplied by the West will not be used to attack Russian territory, Germany’s...

Read more

Pope urges end to ethnic hatred in South Sudan

byAFP
February 5, 2023, 6:20 pm
0
8
UN: World must brace for more extreme, devastating wildfires

Pope Francis appealed Sunday to the people of South Sudan to lay down their “weapons of hatred” at an open-air...

Read more

Pakistan’s former military ruler Pervez Musharraf dies—Army

byAFP
February 5, 2023, 6:10 pm
0
8
Pakistan’s former military ruler Pervez Musharraf dies—Army

Pakistan’s former military ruler Pervez Musharraf has died in Dubai aged 79 after a long illness, the army said Sunday....

Read more

US cargo train derails, causing massive fire

byAFP
February 5, 2023, 6:00 pm
0
8
Southwoods nails Seniors’ Fil golf crown

A cargo train derailed in the midwestern United States, sparking a massive fire and triggering the release of small amounts...

Read more

Nine missing after fishing boat capsizes in South Korea

byAFP
February 5, 2023, 12:00 pm
0
8
Southwoods nails Seniors’ Fil golf crown

Rescue workers were searching by sea and air for nine people missing after a fishing boat capsized in waters off...

Read more

Endangered monarch butterflies face perilous storm

byAFP
February 5, 2023, 11:30 am
0
8
Endangered monarch butterflies face perilous storm

As devastating storms pounded California, nature lovers feared for endangered monarch butterflies that winter there as part of a seemingly magical...

Read more

Print Edition

View More

Recent Posts

  • Sta. Maria Eagles Club
  • Patiently waiting
  • Davao de Oro quake infrastructure damage hits P21 million, OCD says
  • Recto: House boosts budget for cancer treatments to P1.56 billion
  • QC solon pushes 30-day paternity leave for fathers
  • Alfonso Yuchengco: Longer than a centrury
  • SBMA turns over P178.7m to neighboring LGUs
  • Senior Citizen party-list eyes nutrition program

Advertisement

Latest News

Alfonso Yuchengco: Longer than a centrury

byManila Standard
February 5, 2023, 10:09 pm
0
8
Alfonso Yuchengco: Longer than a centrury

On the occasion of the 100th birth anniversary of Ambassador Alfonso T. Yuchengco, February 6, 1923 - April 15, 2017...

Read more

SBMA turns over P178.7m to neighboring LGUs

byManila Standard
February 5, 2023, 10:05 pm
0
8
SBMA to release P123.1M in LGU revenue shares

SUBIC BAY FREEPORT—The Subic Bay Metropolitan Authority (SBMA) officials met with the local chief executives and representatives of this premier...

Read more

Senior Citizen party-list eyes nutrition program

byRio N. Araja
February 5, 2023, 10:00 pm
0
8
Senior Citizen party-list eyes nutrition program

Senior Citizen party-list Rep. Rodolfo Ordanes has filed a counterpart bill to Senate Bill 1799 to lay down a comprehensive...

Read more

Online Payment of DOH Permits, Licenses, Registration in Metro Manila Now Available via www.myeg.ph

byManila Standard
February 5, 2023, 9:45 pm
0
8
Online Payment of DOH Permits, Licenses, Registration in Metro Manila Now Available via www.myeg.ph

In responding to the growing demand for safe and convenient payment services, the Department of Health - Metro Manila Center...

Read more

Digital champions

byManila Standard
February 5, 2023, 9:35 pm
0
8
Scholarship platform

Outstanding microentrepreneurs and microfinance institutions who have successfully transitioned their business to harness digital solutions receive recognition at the 1st...

Read more

Advertisement

ADVERTISEMENT
Facebook Twitter Instagram Youtube

ABOUT US

Manila Standard

Manila Standard website (manilastandard.net), launched in August 2002, extends the newspaper’s reach beyond its traditional readers and makes its brand of Philippine news and opinion available to a much wider and geographically diverse readership here and overseas.

Digital Edition

In tone and content, the online edition mirrors the editorial thrust of the newspaper. While hewing to the traditional precepts of fairness and objectivity, MS believes the news of the day need not be staid, overly long or dry. Stories are succinct, readable and written in a lively style that has become a hallmark of the newspaper.

Download – Today’s Paper

Search

No Result
View All Result

6th Floor Universal Re Bldg., 106 Paseo De Roxas cor. Perea Street, Legaspi Village, 1226 Makati City Philippines

Trunklines: 832-5554, 832-5556, 832-5558

© 2021 Manila Standard - Designed and Developed by Neitiviti Studios.

No Result
View All Result
  • About
  • News
    • Top Stories
    • National
    • World News
    • Pinoy Abroad
    • Features
  • Opinion
    • Editorial
    • Columns
    • Soundbytes
  • LGUs
    • NCR
    • Luzon
    • Visayas
    • Mindanao
  • Business
    • Corporate
    • Economy & Trade
    • Stocks
    • Money
    • Agri & Mining
    • Power & Tech
    • IT & Telecom
  • Sports
    • Basketball
    • Volleyball
    • Fightsports
    • Active
    • Sports Plus
    • One Championship
    • Columns
  • Entertainment
    • TV & Movies
    • Celebrity Profiles
    • Music & Concerts
    • Digital Media
    • Columns
  • Lifestyle
    • Food
    • Culture & Media
    • Fashion
    • Health and Home
    • Leisure
    • Shopping
    • Columns
  • Pop.Life
    • Newsmakers
    • Hangouts
    • A-Pop
    • Post Its
    • Performances
    • Malls & Bazaars
    • Hobbies & Collections
  • Technology
    • Gadgets
    • Computers
    • Business
    • Tech Plus
  • MS ON THE ROAD
    • Sedan
    • SUV
    • Truck
    • Bike
    • Accessories
    • Motoring Plus
    • Commuter’s Corner
  • Home & Design
    • Residential
    • Commercial
    • Construction
    • Interior
  • Spotlight
  • Gallery
    • Photos
    • Videos
  • Events
    • Seminars
    • Exhibits
    • Community
  • Biyahero
    • Travel Features
    • Travel Reels
    • Travel Logs
  • Pets
  • Advertise with Us

© 2021 Manila Standard - Designed and Developed by Neitiviti Studios.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Install Manila Standard Web App

Install App